Procurement Footprint
Pfizer — public-sector procurement footprint
From open OCDS records, AqlData resolved 713 name-spelling variants of Pfizer into one identity (713 legal entities) and mapped its public-sector footprint: 35 countries, ~$40.4B in awarded value (FX-approx, indicative), across 22,406+ tracked contracts (2003-07-21 – 2026-05-28).
35
countries
$40.4B
awarded value *
22,406+
tracked contracts
2,336
public buyers
* ok-quality, FX-converted contracts only (no_value / no_fx / outlier records excluded). Indicative at current spot FX — not historical rates.
Geographic reach
| Country | Contracts | ~Value ($M) |
|---|---|---|
| GB | 302 | 10,155.7 |
| EU | 972 | 8,377.1 |
| IT | 3,628 | 4,423.4 |
| RO | 1,105 | 4,383.9 |
| ES | 1,405 | 3,087.2 |
| FR | 536 | 2,320.1 |
| + 29 more countries | in full report | — |
Top public buyers
| Buyer | Country | Contracts |
|---|---|---|
| Unidade Local de Saúde do Norte Alentejano, E. P. E. | PT | 926 |
| Instituto Português de Oncologia do Porto Francisco Ge | PT | 727 |
| Centro Hospitalar Universitário de Lisboa Norte, E. P. | PT | 433 |
| + 2,333 more buyers — every agency, contract-level | — | in full report |
Activity over time
20151,340
20161,438
20171,777
20182,197
20192,414
20201,902
20211,715
20222,766
20231,643
20241,310
2025594
2026131
The full due-diligence report
All 35 countries, every one of 2,336 public buyers at the contract level, single-customer revenue concentration, the top-5 buyer split and the buyer-level competitor map — the complete Pfizer due-diligence brief, delivered within 24 hours.
Order this report — $499Request a worked sample